Study to assess the knowledge of caretakers regarding corticosteroid therapy in children with congenital adrenal hyperplasia – 21 hydroxylase deficiency
Background: The primary aim of treating congenital adrenal hyperplasia (CAH) due to 21 hydroxylase deficiency is to replace the deficient glucocorticoids and mineralocorticoids, to minimize the excess androgen production and to facilitate normal growth. Children with CAH require daily treatment life...
Main Authors: | Vasantha Singarayan, Anita David, Vageesh Ayyar, Saji James |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=6;spage=2814;epage=2817;aulast= |
Similar Items
-
IS CONGENITAL ADRENAL HYPERPLASIA DUE TO 21- HYDROXYLASE DEFICIENCY DECEPTIVE DISEASE? MANAGEMENT AND DIFFERENTIATION OF SYNDROME IN ADULTS
by: Anna Nowak
Published: (2017-12-01) -
Congenital adrenal hyperplasia
by: Miolski Jelena, et al.
Published: (2021-01-01) -
Rare and severe complications of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a case report
by: Ferreira Florbela, et al.
Published: (2013-02-01) -
Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
by: Mouna Feki Mnif, et al.
Published: (2013-01-01) -
Birth Size in Neonates with Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
by: Helmuth G. Dörr, et al.
Published: (2019-03-01)